Recon: Moderna to layoff 10% of staff; Trump pressures drugmakers to cut US prices
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.In Focus: US
- NIH is shrinking the number of research projects it funds due to a new Trump policy (STAT)
- FDA chief says NIH ‘brewed up a virus that killed 20 million people’ (The Hill)
- Senate confirms Trump nominee to lead CDC (The Hill)
- Trump drove firing of FDA official (Politico)
- Inside the fall of Vinay Prasad at the FDA (STAT)
- US vaccination rates for measles, other diseases drop further, government data says (Reuters)
- Trump pressures 17 pharma CEOs to cut US drug prices (Reuters) (Bloomberg)
- Trump administration proposes pilot initiative to address controversy over 340B drug discount program (STAT)
- Canada has 3 times as many measles cases as US (The Hill)
- Ignoring China's biotech industry is no longer an option. It's a recipe for disaster (Endpoints)
- Neuralink Launches Clinical Trial in Britain to Test Brain Chip (Bloomberg)
- India's Sun Pharma reports higher adjusted quarterly profit on strong domestic demand (Reuters)
- Weight loss drugs may boost testosterone in men, study finds (The Hill)
- Lilly’s diabetes drug Mounjaro matches heart benefit of older treatment (STAT)
- Alnylam raises revenue outlook as heart drug sees quick uptake (STAT)
- Moderna lays off 10% of workforce in further cost-cutting move (STAT) (Reuters)
- With $1.3 billion in hand, VC firm Frazier remains bullish on biotech (STAT)
- Using mRNA, scientists overcome a key challenge to HIV vaccines (STAT)
- AbbVie again hikes guidance as it eyes neuro, obesity and PD-1xVEGF deals (Endpoints)
- Bristol Myers raises revenue guidance for the year, prepares for major Cobenfy readouts (Endpoints)
- Fiat Heir Elkann Ditches Trucks for Bytes, Brands and Biotech (Bloomberg)
- Cigna's health services business powers Q2 earnings beat (Reuters)
- Biogen signals Leqembi sales gaining momentum, lifts profit forecast (Reuters)
- 6 burning questions about the White House health tech pledge (STAT)
- Sword moves beyond digital physical therapy (Endpoints)
- Dexcom raises sales expectations, discusses G8 plans (MedTech Dive)
- Trump administration launches health data sharing initiative (MedTech Dive)
- GE HealthCare projects reduced tariff expense (MedTech Dive)
- Biostate AI Builds Global RNA-AI Pipeline With $12M Boost, Ventures In China And India (MedTech Insight)
- Trump’s Brazil Tariffs Upend Crop Prices From Coffee to Juice (Bloomberg)
- Chobani sued by Danone for allegedly copying cold brew packaging (Food Dive)
- Top White House pandemic preparedness official resigns, officials say, in sign of broader disarray (STAT)
- Researchers sequence complex parts of human genome, expanding the future of precision medicine (STAT)
- Warren questions HHS general counsel nominee about vaccines, abortion (The Hill)
- Cooper’s North Carolina Senate bid will put Medicaid front and center (The Hill)
- The Vaccine Injury Compensation Program needs to be updated, not eliminated (STAT)
- A Tip of the Hat to Retiring DEA Chief ALJ Mulrooney (FDA Law Blog)
A story’s inclusion in Regulatory Recon does not imply endorsement by Regulatory Focus or RAPS.
